Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Taxane and Carboplatin|DRUG: Short-term Sintilimab|PROCEDURE: Surgery
Sponsor: Shanghai Jiao Tong University School of Medicine
Collaborators: Innovent Biologics, Inc.|CSPC Ouyi Pharmaceutical Co., Ltd.